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Abstract
Leukocyte telomere length (LTL) provides a potential marker of biological age, closely related to the endothelial dysfunction
and consequently to the atherosclerotic process. To investigate the relationship between the LTL and the risk of premature
acute myocardial infarction and to evaluate the predictive value of LTL on the onset of major cardiovascular events, 199
patients from 18 to 48 years old with first diagnosis of acute myocardial infarction were enrolled and were matched with
190 controls for sex and age (61 year). Clinical data and coronary artery disease were evaluated at enrollment and at follow
up. LTL was measured at enrollment using a quantitative PCR-based method. No significant differences were observed in
LTL between cases and controls (p = 0.20) and with the presence of coronary artery disease in patients (p = 0.47).
Hypercholesterolemic cases presented LTL significantly longer than cases without hypercholesterolemia (t/s: 0.8260.16
p = 0.79 and t/s norm: 0.7960.19 p = 0.01), as confirmed in multivariate regression analysis (p = 0.005, b= 0.09). Furthermore,
multivariate regression analysis showed LTL significantly shorter in hypertensive cases than in normotensive cases (p = 0.04,
b=20.07). One hundred seventy-one cases (86%) ended the average follow up of 965 years, 92 (54%) presented a major
cardiovascular event. At multivariate regression analysis the LTL detected at enrollment did not represent a predictive factor
of major cardiovascular events nor it significantly impacted with cumulative events. Based on present cohort of young
Italian patients, the LTL did not represent a marker of acute myocardial infarction nor had a predictive role at medium term
follow up.
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Introduction
Coronary heart disease (CHD) is an age related disease, and
aging is considered a major risk factor of atherosclerosis [1].
Ischemic heart disease occurring in young adults is an uncommon
finding, representing from 4 to 10% of the total case population
[2], and it is associated in the majority of cases with a premature
coronary artery disease (CAD) [3]. Even if the juvenile CHD is less
frequent, it is a major health burden with an unfavorable prognosis
at medium-long term [4].
Recent evidence [5] support a close relationship between the
biological age and atherosclerotic process indicating that the
mechanisms involved in cellular senescence might have a role in
endothelial dysfunction. According to this, it should be remarkable
to find a marker of cellular biological age able to predict the risk of
early onset of atherosclerosis and consequently of a premature
CHD. An increasing interest is focused on telomere, tandem
repeat DNA sequences situated at the ending part of the
eukaryotic chromosomes [6], that progressively shorten during
the cell divisions critically influencing the senescence and
programmed cell death. The telomere length represents therefore
a sort of biological cell clock and shorter telomeres reflect a more
advanced biological age [7]. Short telomeres, in fact, have been
detected in senescent endothelial cells present in atherosclerotic
plaques [5,8] and telomeres are remarkably shorter in patients
with aging associated disease such coronary artery disease and
chronic heart failure [9]. Nevertheless, the studies published so far
investigated the relationship between mean telomere length and
the cardiovascular disease only in middle age subjects [10,11] and
at present few studies are suitable to determine the actual role of
telomere length in the beginning of acute myocardial infarction in
young adults.
The aim of the present case-control study is to evaluate the
relationship between the leukocyte telomere length (LTL) and the
risk of premature acute myocardial infarction in a cohort of Italian
patients aged #48 years old. Moreover, we prospectively
evaluated the patients during a medium term follow up to assess
the prognostic impact of LTL with the onset of major acute
cardiovascular event (MACE).
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Methods
Participants
The case-control study enrolled 199 patients with first diagnosis
of acute myocardial infarction (AMI) at #48 years old consecu-
tively admitted in our Coronary Care Unit from March 1992 to
May 2009 and 190 controls, frequency matched for age and sex.
The AMI was diagnosed according to criteria of the Joint
European Society of Cardiology/American College of Cardiology
Committee [12]. All the subjects enrolled had Italian nationality.
All controls selected were free of previously diagnosed cardiovas-
cular disease or cancer. All subjects were interviewed with
a standardized questionnaire concerning the following cardiovas-
cular risk factors: smoking habits, hypertension, diabetes, hyper-
cholesterolemia, body mass index (BMI), family history of CAD.
All definitions were based on those recommended in the European
guidelines on cardiovascular disease prevention in clinical practice
issued 1998 [13]. In patients the following measurements were also
collected: electrocardiographic presentation at AMI (with ST
segment elevation myocardial infarction, STEMI or without ST
segment elevation myocardial infarction, NSTEMI); left ventric-
ular ejection fraction (LVEF) and coronary vessel disease assessed
by coronary angiography during the hospitalization.
Follow-up ended in April 2010 with an outpatient visit or, if not
possible, a telephone interview. All patients answered to the same
standardized questionnaire completed at baseline. Cardiovascular
events were defined as cardiac death, recurrent AMI, heart failure
needing hospitalization, stroke and angina pectoris needing
a revascularization procedure [14]. Dead patients were assessed
during follow-up also through demographic and hospital records.
The patients were enrolled after giving written informed
consent concerning the study. This study was performed according
to the principles of the Declaration of Helsinki and in agreement
with ethical requirements. An internal ethical review board at
HuGeF (Human Genetics Foundation Ethics committee/17-11-
2011) approved the study. No sex-based or ethnic-based differ-
ences were present; most of the subjects are of Caucasian origins.
Measurement of Leukocyte Telomere Length
All subjects enrolled underwent a venous blood sample drawn.
Leukocyte DNA was extracted by the salting-out method. DNA
concentration was measured with NANODROP 8000 (Thermo-
Scientific) and all samples have been diluted to a fixed concen-
tration of 2 ng/ml.
The total amount of telomeric DNA was measured by Real-
Time Quantitative PCR, by measuring for each sample the
relative amount of telomeric DNA (t) as compared to the amount
of a single copy gene DNA (s) in the same sample (t/s ratio).
Real Time PCR telomeric DNA measurement and single gene
DNA measurement were performed in separate plates due to
different annealing temperatures of the specific primers.
To guarantee comparability between plates, a commercial DNA
(Human DNA Male, Applied Biosystems) used as calibrator was
plated in each PCR run.
A second commercial DNA (Human DNA Male, Applied
Biosystems) was diluted serially to produce a 5-point standard
curve (ranging 20 to 1.25 ng DNA) and was included in each plate
to measure the telomeric and single copy gene DNA amounts.
The gene 36B4, which encodes the acidic ribosomal phospho-
protein P0, was used as single copy reference gene as described in
Cawthon [15].
Primers sequences [35] and annealing temperatures were as
follows:
TEL 1 - 59 CGG TTT GTT TGG GTT TGG GTT TGG
GTT TGG GTT TGG GTT - 39.
TEL 2 - 59 GGC TTG CCT TAC CCT TAC CCT TAC CCT
TAC CCT TAC CCT - 39.
36B4 1- 59 CAG CAA GTG GGA AGG TGT AAT CC - 39.
36B4 2 - 59 CCC ATT CTA TCA TCA ACG GGT ACA A -
39.
A total 15 ml of PCR mix containing 1X SYBR Green (Power
SYBRH Green PCR Master Mix, Applied Biosystems), 0.2 pmol/
ml each primer and 4 ng genomic DNA was prepared for each
sample. Each sample as well as calibrator sample and standard
curve points were run in triplicate.
Cycling conditions were as follows: 95uC67 m [95uC615 s,
54uC 6 2 m]630 for PCR amplification of telomeric regions;
95uC 6 7 m [95uC 6 15 s, 58uC 6 1 m]640 for PCR
amplification of 36B4 gene.
To check for PCR reaction specificity, a melting analysis step
was included at the end of each PCR run: no non-specific PCR
product was detected.
A 7900HT Fast Real-Time PCR System (Applied Biosystems)
with SDS Software version 2.3 (Applied Biosystems) was used. All
PCR runs were inspected by a trained operator, and the threshold
value suitable for the analysis of all the PCR batches was chosen.
The t/s of all the samples has been compared with the t/s of the
same commercial DNA (Human DNA Male, Applied Biosystems)
in order to calculate a t/s normalized ratio (t/s norm) for each
sample.
The commercial DNA included in all the plates showed low
variability (coefficient of variation 36B4CtCTR=1.46%; coefficient
of variation TELCtCTR= 1.36%) in Threshold Cycle (Ct) values
among different PCR batches (n = 5), confirming a good re-
peatability of the assay.
In our experimental conditions the standard curves’ correlation
coefficients were all R2.0.99.
Leukocyte telomere length from 30 healthy individuals (age
range 22–61) were measured by Real-Time Quantitative PCR and
compared with relative mean TRF lengths (manuscript in
preparation) in the same samples measured by traditional
Southern blot methods [36]. The Pearson correlation coefficient
between these two different approaches to measuring telomeres
was 0.6 (p,0.001). The same 30 samples were run in two different
times to assess measurement variability and the Pearson correla-
tion coefficient was 0.7 (p,0.0001).
Statistical Methods
We tested for the differences between two groups (case-control
status, above and below the median of normalized t/s ratio, and
other dichotomic categorical variables ) using the non-parametric
Wilcoxon sum rank test.
We performed multivariate regression analysis using a general
linear model (case-control status as dependent variable) including
all the variables of interest (hypertension, hypercholesterolemia,
diabetes, familiar history of CAD, smoking status and BMI) and
adjusting for age and sex as covariates. The probability of survival
to the different outcome events over time for each group was
calculated according to the Kaplan-Meier method and compared
by log-rank test. All the analyses have been done for t/s ratio and
for normalized t/s ratio, however, data are presented only for the
latter. Data were analysed using SAS V 9.2 and STATA v 10.0.
Results
The baseline characteristics and the main cardiovascular risk
factors are shown in Table 1. Eighty-nine percent of patients were
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males. The main cardiovascular risk factors recorded in patients
were the smoking (82% vs 40%, p,1024), the family history for
CAD (61% vs 17%, p,1024) and the hypertension (38% vs 7%,
p,1024). Moreover, the cases were most frequently hypercholes-
terolemic respect to the controls (61% vs 31%, p,1024), with
a higher prevalence of diabetic subjects among cases (13% vs 2%,
p,1024). The majority of patients (69.8%, 139 patients) presented
a STEMI and the LVEF was in general preserved (LVEF:
54%610.5%). The mean LTL in cases was not statistically
different from the controls (t/s norm: 0.7760.19 vs 0.7660.19
p= 0.20, from Wilcoxon sum rank test). There was no correlation
between LTL and age, neither in cases (t/s norm, r =20.001,
p = n.s.) nor in controls (t/s norm, r =20.001, p = n.s.). Concern-
ing the cardiovascular risk factors, we did not find a significant
association between hypertension and LTL in either cases (t/s
norm, p= 0.06) and controls (t/s norm, p= 0.8) using the
Wilcoxon sum rank test (Table 2), however, multivariate re-
gression analysis showed LTL significantly shorter in hypertensive
cases (p = 0.04, b=20.07). Furthermore, hypercholesterolemic
cases had LTL significantly longer than cases without hypercho-
lesterolemia (t/s norm:0.7960.19 p= 0.01) (Table 2) as confirmed
at multivariate regression analysis (p = 0.005, b=0.09). The lack of
significant associations between hypercholesterolemia as well as
hypertension and LTL in controls can be due to the lower
frequency of these risk factors among them. No significant
relationship (Table 2) was found between LTL and family history
of CAD, (t/s norm, p= 0.64) in cases. Among controls, subjects
with family history of CAD had LTL longer than controls without
family history (t/s norm: 0.8860.14 p= 0.002) (Table 3), data
confirmed at linear regression analysis (p = 0.03). Regarding the
analysis of LTL vs the presence of coronary artery disease, our
data did not reveal any statistically significant correlation (t/s
norm, p= 0.46) (Table 4).
About 86% of patients enrolled (171 cases) completed the
follow-up. During a medium period of 965 years 92 out of 171
(54%) remaining patients presented a MACE. AMI occurred in 37
patients, a percutaneous coronary intervention due to angina was
performed in 35 patients and 17 died for cardiac death. Only 1
case presented a stroke and 2 patients were hospitalized for heart
failure. The LTL detected at enrollment did not significantly
impact with the composite CVD end-point (Figure 1A and
Figure 1B), nevertheless, as shown in Figure 1B, cases with shorter
LTL seemed to have a worse prognosis considering the first five-
year after AMI, although the difference was not statistically
significant.
Discussion
In this Italian prospective case-control study, we did not show
neither a significant association between the LTL and the AMI
occurred in young adults nor a relationship between the LTL and
the onset of MACE during a medium term follow up.
In contrast with our results, Maubaret et al. [11] in HIFMECH
(hypercoagulability and impaired fibrinolytic function mechanisms
predisposing to myocardial infarction) study have shown a signif-
icant relationship between LTL and incidence of AMI in patients
,60 years, suggesting that shorter LTL could be a marker of
coronary heart disease in a later age. Same results were reported
by Brouilette et al. [16] in a case control study conducted in
English patients with AMI at 50 years or less and by the same
author in West of Scotland Primary Prevention Study (WOS-
COPS study) [10] in middle aged men (45–64 years). Finally Zee
et al. observed that mean LTL was shorter in subjects who
developed AMI than in subjects who did not [17].
Our study is the first to investigate the LTL in a well-selected
Italian survey and our data do not reveal a significant difference in
LTL between case and controls. However, the enrolled patients in
Table 1. Baseline characteristics of 199 cases and 190
controls at enrollment.
Characteristics Cases N (%) Controls N (%) P-value
Males 178 (89.4) 173 (91.1) ns
Age 40.165 39.865 ns
Smoking Yes 155 (82) 65 (39.6) ,1024
No 34 (18) 99 (60.4)
Family history of CAD Yes 120 (61.2) 14 (16.5) ,1024
No 76 (38.8) 71 (83.5)
Hypertension Yes 74 (37.8) 12 (7.3) ,1024
No 122 (62.2) 152 (92.7)
Hypercholesterolemia Yes 116 (61) 49 (30.6) ,1024
No 75 (39.3) 111 (69.4)
Total cholesterol 214.4648 207.8636 ns
Triglycerides 156.56112 107.4661 ,1024
LDL 136.66105 125.4638 ns
HDL 49.8618 57.6614 ,1024
Diabetes Yes 26 (13.3) 3 (1.8) ,1024
No 170 (86.7) 161 (98.2)
BMI Yes 105 (60.3) 64 (45.1) 0.007
No 69 (39.7) 78 (54.9)
BMI 26.565 24.963 1024
Data are shown as percentages for categorical variables and means for
continuous variables. CAD, coronary artery disease; BMI, body mass index; LDL,
low density lipoprotein; HDL, high density lipoprotein.
Active smokers were included in the group of smokers whereas subjects who
have never smoked or who have stopped smoking for ten years or more were
considered as non-smokers.
Hypertensive participants were defined by systemic blood pressure $140/
90 mmHg or treatment with antihypertensive therapy.
Hypercholesterolemia was determined by total cholesterol .220 mg/dl.
Obesity was defined by BMI .25 kg/m2.
Diabete was determined by medical history or fasting blood glucose .126 mg/
dl on two testing occasions or glucose overload test.
doi:10.1371/journal.pone.0049206.t001
Table 2. Wilcoxon sum rank test on leukocyte telomere
length presented t/s ratio normalized and cardiovascular risk
factors of cases (n = 199).
Variable LTL (t/s norm) p value
Male sex (M vs F) 0.7760.19 vs 0.7160.19 0.20
Smoking (Ever vs Never) 0.7660.20 vs 0.8060.17 0.45
Hypertension (Yes vs No) 0.7460.18 vs 0.7960.20 0.06
Hypercholesterolemia (Yes vs No) 0.7960.19 vs 0.7260.19 0.01
Diabetes (Yes vs No) 0.8060.17 vs 0.7660.20 0.47
Family history of CAD (Yes vs No) 0.7860.19 vs 0.7660.20 0.64
Data are presented as means and standard deviation. LTL, leukocyte telomere
length; CAD, coronary artery disease.
doi:10.1371/journal.pone.0049206.t002
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Brouilette et al. [10,16] and in Zee et al. [17] were in average older
than our patients, not a trivial aspect, considering that the
telomere length decreases progressively with age and in the
younger patients the expected major activity of DNA repair
systems could determine a minor telomere shortening.
Our cohort is similar for risk profile to the juvenile populations
investigated by previous studies [2,18,19] and in particular our
patients are representative of an Italian survey of juvenile AMI
[20] being the majority of cases smokers, hypercholesterolemic,
hypertensive and presenting a family history for CAD.
Regarding a possible correlation between the LTL and a family
history of CAD, Salpea et al. [21] demonstrated in the European
Atherosclerosis Research Study II (EARSII) a shorter LTL in
young male students with a paternal history of premature
myocardial infarction with respect to the age-matched controls
with no family history of CAD. We found a longer LTL in controls
with family history of CAD respect to the controls without family
history (t/s norm: 0.8860.14 p= 0.002), data confirmed at linear
regression analysis (p = 0.03), whereas in cases with positive family
history the LTL was slightly shorter respect to the cases with no
history of CAD, although the difference was not statistically
significant (p = 0.10).
Although the discordant results can be due to the limited
number of subjects with family history in our study sample, mean
age and health status could partly explain the differences with the
study of Salpea et al. (2009) [21].
Some evidence suggest that telomere shortening may play a role
in pathogenesis of hypertension [22] probably inducing genomic
instability related to an early cellular senescence, as reported also
by Giannotti et al. [23] who described a shorter telomere length in
progenitor endothelial cells of prehypertensive and hypertensive
patients. In a recent study Yang et al. [24] found a significant
correlation between shorter LTL and hypertensive subjects in
a Chinese population [25]. Moreover, in previous studies an
inverse correlation was observed between pulse pressure [26,27],
pulse wave velocity [26] and LTL. Our data showed no significant
association between hypertension and LTL neither in cases nor in
controls using the Wilcoxon sum rank test, nevertheless hyperten-
sive cases presented a shorter telomere length after correction for
other risk factors (p = 0.04) at linear regression analysis. As already
described, our cases are on average younger than patients
considered in the above mentioned studies on hypertension,
which is more clearly related to ageing than other risk factors (e.g.,
hypercholesterolemia).
We also found a significant association between hypercholes-
terolemia and LTL in cases, with longer LTL in cases with
hypercholesterolemia. When we examined the correlation of total
cholesterol, HDL and LDL with LTL, we found that HDL
positively correlated with LTL with borderline significances in
cases and controls together (t/s norm r=0.1, p = 0.069). These
results are consistent with a recent study in which total cholesterol
was positively associated with LTL [28], as well as reduced HDL
levels have been described associated with shorter LTL in healthy
young adults [29]. According to Ramin Farzaneh-Far et al. [30], it
is possible that individuals with shorter telomeres in proximity of
a critical threshold, can reactivate their enzyme telomerase
(usually active at low levels in peripheral blood leukocytes) leading
to a feedback regulation responsible for the increasing of LTL.
Previous studies [5,8] showed an association with shorter
telomere length and atherosclerosis revealing that endothelial cell
senescence induced by telomere shortening may contribute to
atherogenesis but few studies investigated directly the association
between mean LTL and the coronary artery disease. Mainous
et al. [31] reported in a cohort of 325 patients aged 40–64 years
free of previously diagnosed CVD an inverse correlation between
the telomere length and the coronary artery calcification, whereas
De Meyer et al. [32] in the Asklepios study demonstrated that LTL
is not an independent determinant of atheromatous plaques
present in patients free from established CVD. In our limited
sample, we did not show any relationship between LTL and
coronary artery disease, the telomere length in fact did not differ
significantly in cases with normal coronary at angiography respect
patients with a vessel disease. Although Wilson et al. [33] showed
that the leukocyte telomere DNA content predicts vascular
telomere DNA content, the leukocyte telomere length still
represents a surrogate marker of the endothelial telomere length.
In fact, one of the main limitations of this study, as of many other
above mentioned studies, is that we are measuring TL in
leukocytes.
Moreover, studies with longer follow-up are necessary to better
understand the role of LTL in coronary artery disease.
During a median follow up of 965 years, the majority of
patients remained in the study at the last follow up, 54% of these
presented a MACE. Our data show an unfavorable prognosis at
medium term, confirming the results of Fournier et al. [4] who
reported an event-free survival rates at 10 years of 60%, in a cohort
Table 3. Wilcoxon sum rank test on leukocyte telomere
length presented t/s ratio normalized and cardiovascular risk
factors of controls (n = 190).
Variable LTL (t/s norm) p value
Male sex (M vs F) 0.8060.18 vs 0.7660.20 0.36
Smoking (Ever vs Never) 0.8460.19 vs 0.8060.18 0.28
Hypertension (Yes vs No) 0.8160.12 vs 0.8260.19 0.78
Hypercholesterolemia (Yes vs No) 0.8160.17 vs 0.8260.19 0.92
Diabetes (Yes vs No) 0.9160.04 vs 0.8260.18 0.29
Family history of CAD (Yes vs No) 0.8860.14 vs 0.7160.18 0.002
Data are presented as means and standard deviation. LTL, leukocyte telomere
length; CAD, coronary artery disease.
doi:10.1371/journal.pone.0049206.t003
Table 4. Wilcoxon sum rank test on leukocyte telomere length presented t/s ratio normalized and coronary artery disease in
patients.
LTL (t/s norm) p value
Normal coronary artery (n = 22) vs coronary artery disease (n = 170) 0.8160.14 vs 0.7760.20 0.46
Monovessel disease (n = 96) vs Multivessel disease (n = 72) 0.7560.20 vs 0.7960.19 0.22
Data are presented as means and standard deviation. LTL, leukocyte telomere length.
doi:10.1371/journal.pone.0049206.t004
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of patients affected by AMI at#40 years old and of Fornengo et al.
[34] who found a poor five-year prognosis of juvenile AMI with
one in every five patients presenting a new cardiovascular event.
The measurement of LTL at enrollment did not result to be an
independent predictor of any MACE at follow up nor it
significantly impacted with cumulative survival, describing a lack
Figure 1. A, Event free survival from major cardiovascular events in patients on basis of leukocyte telomere length at enrollment
measured as t/s. B, Event free survival from major cardiovascular events in patients on basis of leukocyte telomere length at enrollment measured
as t/s normalized.
doi:10.1371/journal.pone.0049206.g001
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of association with coronary artery disease in young patients (#48
years old).
Finally, we did not find a correlation between age and telomere
length probably due to the narrow age range (18–48 years) of our
population, which is probably the most flattened area of the LTL-
age curve. This result is in agreement with the study of Jeanclos
et al. [27] in which subjects were 18 to 44 years old and with
Salpea et al. [21] who studied subjects ranging 18 to 28 years old.
It appears, moreover, that different phases in the rate of telomere
attrition exist throughout life. The initial phase (i.e., birth to 5
years) is marked by a relatively high rate of telomere attrition. The
subsequent phase that includes adolescence and young adulthood
is marked by an apparent stabilization of telomere length.
Thereafter, telomere attrition resumes at a slower rate than
during the first 5 years of life [37]. The majority of subjects we
studied were within the age range in which the rate of telomere
attrition slows down or levels off altogether, accounting for the lack
of correlation between the telomere length and age in this group.
To summarize, in this Italian cohort of patients aged #48 years
old, LTL did not represent neither a marker of premature
myocardial infarction nor a predictor of MACE at medium term
follow up. Although current data revealed that the LTL is a marker
of biological aging and, side by side, of the cardiovascular disease,
further studies are mandatory to evaluate the effective roles of
leukocyte telomere length and the use as biomarker for coronary
heart disease occurring in young patients.
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